Diisopropylfluorophosphate inhibits choline efflux from the perfused rat hemidiaphragm

William R. Millington, Allen C. Myers, George G. Bierkamper

Research output: Contribution to journalArticle

Abstract

Acethylcholine (ACh) synthesis by motor nerve terminals requires an adequate supply of its precursor, choline. The results reported here show that diisopropylfluorophosphate (DFP), an acetylcholinesterase inhibitor commonly used in ACh release studies, reduces the rate of endogenous choline efflux from the perfused rat hemidiaphragm. Perfusion of the isolated hemidiaphragm with 10 μM or 100 μM DFP reduced choline efflux by 39% and 69% respectively. DFP administration to rats (6 mg/kg) also lowered the in vitro release of choline by 33%. The rate of ACh release from hemidiaphragm preparations perfused with DFP was significantly lower than the rate of release from preparations perfused with physostigmine, an acetylcholinesterase inhibitor which had no effect on choline efflux. The addition of choline (10-30 μm) to the perfusion medium restored the rate of ACh release from DFP-treated hemidiaphragms but did not further elevated ACh release from physostigmine-treated preparations. These results demonstrate that DFP inhibits choline efflux from the isolated hemidiaphragm and further suggest that, by limiting the availability of choline for ACh synthesis, DFP reduces the rate of ACh release.

Original languageEnglish (US)
Pages (from-to)37-44
Number of pages8
JournalEuropean Journal of Pharmacology
Volume115
Issue number1
DOIs
StatePublished - Sep 10 1985

Keywords

  • Acetylcholine
  • Acetylcholinesterase
  • Choline
  • Diisopropylfluorophosphate
  • Neuromuscular junction
  • Organophosphorus compounds

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Fingerprint Dive into the research topics of 'Diisopropylfluorophosphate inhibits choline efflux from the perfused rat hemidiaphragm'. Together they form a unique fingerprint.

  • Cite this